Biomea Fusion, Inc.
BMEAAs of the close on Sep 25, 2026
Price
$1.32
Market cap
$95.7M
P/E (diluted TTM)
—
A per-share figure for one of the last four quarters is not shown, so no four-quarter total is given
EPS (TTM)
—
A per-share figure for one of the last four quarters is not shown, so no four-quarter total is given
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Biomea Fusion, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 12, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| LMR Partners LLP | 2026-03-31 | 200,000 | Not shown | SEC filing |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2026-03-31 | 310,514 | Not shown | SEC filing |
| GOLDMAN SACHS GROUP INC | 2026-03-31 | 75,739 | Not shown | SEC filing |
| Vanguard Personalized Indexing Management, LLC | 2026-03-31 | 13,703 | Not shown | SEC filing |
| Mariner, LLC | 2026-03-31 | 654,578 | Not shown | SEC filing |
| RENAISSANCE TECHNOLOGIES LLC | 2026-03-31 | 1,312,798 | Not shown | SEC filing |
| RHUMBLINE ADVISERS | 2026-03-31 | 1,200 | Not shown | SEC filing |
| JANE STREET GROUP, LLC | 2026-03-31 | 275,655 | Not shown | SEC filing |
| Quadrature Capital Ltd | 2026-03-31 | 46,162 | Not shown | SEC filing |
| SBI Securities Co., Ltd. | 2026-03-31 | 7,079 | Not shown | SEC filing |
| STATE STREET CORP | 2026-03-31 | 208,015 | Not shown | SEC filing |
| CITIGROUP INC | 2026-03-31 | 4,000 | Not shown | SEC filing |
| BARCLAYS PLC | 2026-03-31 | 51,606 | Not shown | SEC filing |
| Rockefeller Capital Management L.P. | 2026-03-31 | 2,000 | Not shown | SEC filing |
| MAI Capital Management | 2026-03-31 | 89,100 | Not shown | SEC filing |
| GROUP ONE TRADING LLC | 2026-03-31 | 41,519 | Not shown | SEC filing |
| Shay Capital LLC | 2026-03-31 | 10,000 | Not shown | SEC filing |
| BNP PARIBAS FINANCIAL MARKETS | 2026-03-31 | 1,053 | Not shown | SEC filing |
| NORTHERN TRUST CORP | 2026-03-31 | 208,965 | Not shown | SEC filing |
| MORGAN STANLEY | 2026-03-31 | 346,742 | Not shown | SEC filing |
- Each value is checked against Biomea Fusion, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- DIMENSIONAL FUND ADVISORS LP: 25,339 shares reported 2025-12-31; 25,339 shares reported 2026-03-31.
- OSAIC HOLDINGS, INC.: 8,000 shares reported 2025-12-31; 6,000 shares reported 2026-03-31.
- WELLS FARGO & COMPANY/MN: 1 share reported 2025-12-31; 1 share reported 2026-03-31.
- BRIDGEWAY CAPITAL MANAGEMENT, LLC: 68,300 shares reported 2025-12-31; 84,600 shares reported 2026-03-31.
- ADAR1 Capital Management, LLC: 43,420 shares reported 2025-12-31; 43,420 shares reported 2026-03-31.
- SIGNATUREFD, LLC: 3,500 shares reported 2025-12-31; 3,500 shares reported 2026-03-31.
- ROYAL BANK OF CANADA: 460 shares reported 2025-12-31; 234 shares reported 2026-03-31.
- GEODE CAPITAL MANAGEMENT, LLC: 562,898 shares reported 2025-12-31; 548,186 shares reported 2026-03-31.
- PNC FINANCIAL SERVICES GROUP, INC.: 24,000 shares reported 2025-12-31; 24,000 shares reported 2026-03-31.
- UBS Group AG: 379,464 shares reported 2025-12-31; 515,555 shares reported 2026-03-31.
- FEDERATED HERMES, INC.: 311,099 shares reported 2025-12-31; 6,969 shares reported 2026-03-31.
- JONES FINANCIAL COMPANIES LLLP: 128 shares reported 2025-12-31; 128 shares reported 2026-03-31.
Showing the 12 most recent filer reports.
29 filers have only one report here.
Independent insiders buying near the same time
- 2025-11-28–2025-12-02: 3 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
- 2022-11-11–2022-11-14: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2021-09-17–2021-09-17: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2021-08-17–2021-08-23: 6 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-11 | Erdtmann Rainer M · See Remarks | Common Stock | P — Open market or private purchase | +30,000 | 1.43 | SEC filing |
| 2025-12-02 | Hitchcock Michael J.M. · Interim CEO | Common Stock | P — Open market or private purchase | +100,000 | 0.99 | SEC filing |
| 2025-12-01 | Erdtmann Rainer M · See Remarks | Common Stock | P — Open market or private purchase | +10,000 | 1.05 | SEC filing |
| 2025-11-28 | Erdtmann Rainer M · See Remarks | Common Stock | P — Open market or private purchase | +40,000 | 1.10 | SEC filing |
| 2024-09-30 | Hitchcock Michael J.M. · Director | Common Stock | P — Open market or private purchase | +10,000 | 10.06 | SEC filing |
| 2024-06-11 | Valle Franco · Chief Financial Officer | Common Stock | P — Open market or private purchase | +12,509 | 4.43 | SEC filing |
| 2023-06-01 | A2A Pharmaceuticals, Inc. · 10% owner | Common Stock | S — Open market or private sale | −50,000 | 34.56 | SEC filing |
| 2023-05-31 | A2A Pharmaceuticals, Inc. · 10% owner | Common Stock | S — Open market or private sale | −75,000 | 33.81 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-10 | Averill Julianne · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +173,711 | SEC filing |
| 2026-06-10 | AGUIAR ERIC · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +196,299 | SEC filing |
| 2026-06-10 | Ray Sumita · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +196,299 | SEC filing |
| 2026-06-10 | Faust Elizabeth · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +196,299 | SEC filing |
| 2026-04-01 | Hitchcock Michael J.M. · Interim CEO | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +667,477 | SEC filing |
| 2026-04-01 | Erdtmann Rainer M · See Remarks | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +452,512 | SEC filing |
| 2025-12-31 | Erdtmann Rainer M · See Remarks | Common Stock | G — Bona fide gift | −50,000 | SEC filing |
| 2025-12-31 | Erdtmann Rainer M · See Remarks | Common Stock | G — Bona fide gift | +50,000 | SEC filing |
Showing 8 of 22 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2022-06-01 | Biomea Health, LLC · 10% owner | Common Stock | J — Other acquisition or disposition | −4,365,342 | SEC filing |
Showing 1 of 1 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.